These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29914760)

  • 1. Three cases of monoclonal gammopathy of renal significance after kidney transplantation. De novo C3 glomerulopathy.
    Serra N; Facundo C; Canal C; Arce Y; Ayasreh N; Vila A; Bardají B; Silva I; López V; Benito S; Ballarín J; Guirado L
    Nefrologia (Engl Ed); 2019; 39(2):198-201. PubMed ID: 29914760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
    Sethi S; Fervenza FC; Rajkumar SV
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant Monoclonal Gammopathy of Renal Significance: A Case Series.
    Rana R; Cockwell P; Pratt G; Cook M; Drayson M; Vydianath B; Neil D; Pinney JH
    Transplant Proc; 2020 Apr; 52(3):857-864. PubMed ID: 32143865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 78-Year-Old Man with Chronic Kidney Disease and Monoclonal Gammopathy Who Developed Post-Transplant C3 Glomerulopathy - Recurrence or De Novo? A Case Report and Literature Review.
    Ruiz-Fuentes MC; Caba-Molina M; Polo-Moyano A; Palomares-Bayo M; Galindo-Sacristan P; De Gracia-Guindo C
    Am J Case Rep; 2023 Jun; 24():e939726. PubMed ID: 37329130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C3 Glomerulonephritis Associated with Monoclonal Gammopathy of Renal Significance.
    Gomes-Alves I; Castro-Ferreira I
    Acta Med Port; 2021 May; 34(5):372-377. PubMed ID: 33819437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-Transplant Monoclonal Gammopathy of Renal Significance: A Case Report.
    Movilla Echeverri C; Montilla Cosano G; Rivera Garrido C; Suñer Poblet M; Suarez Benjumea A
    Transplant Proc; 2023 Dec; 55(10):2301-2303. PubMed ID: 38030424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series.
    Heybeli C; Alexander MP; Bentall AJ; Amer H; Buadi FK; Dean PG; Dingli D; Dispenzieri A; El Ters M; Gertz MA; Issa NS; Kapoor P; Kourelis T; Kukla A; Kumar S; Lacy MQ; Lorenz EC; Muchtar E; Murray DL; Nasr SH; Prieto M; Rajkumar SV; Schinstock CA; Stegall MD; Warsame R; Leung N
    Am J Kidney Dis; 2022 Feb; 79(2):202-216. PubMed ID: 34175375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of monoclonal gammopathy of undetermined significance and C3 glomerulopathy.
    Ekladious A; Bhandari R; Javaid MM
    Intern Med J; 2023 Sep; 53(9):1712-1715. PubMed ID: 37665716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update to the pathogenesis for monoclonal gammopathy of renal significance.
    Zuo C; Zhu Y; Xu G
    Ann Hematol; 2020 Apr; 99(4):703-714. PubMed ID: 32103323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.
    Alonso-Titos J; Perea-Ortega L; Sola E; Torres-Rueda A; León M; Toledo R; Duarte AD; Vazquez T; Martinez-Esteban MD; Bailen A; Ruiz-Esteban P; Hernandez D
    BMC Nephrol; 2018 Jun; 19(1):129. PubMed ID: 29884135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.
    Hirashio S; Satoh A; Arima T; Mandai K; Awaya T; Oshima K; Hara S; Masaki T
    BMC Nephrol; 2018 May; 19(1):108. PubMed ID: 29724182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
    Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
    Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies.
    Caravaca-Fontán F; Lucientes L; Serra N; Cavero T; Rodado R; Ramos N; Gonzalez F; Shabaka A; Cabello V; Huerta A; Pampa-Saico S; Gutiérrez E; Quintana LF; López-Rubio ME; Draibe J; Alonso Titos J; Fernández-Juárez G; Goicoechea de Jorge E; Praga M
    Nephrol Dial Transplant; 2022 Oct; 37(11):2128-2137. PubMed ID: 34677610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of monoclonal gammopathy of renal significance.
    Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
    Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance.
    Sprangers B; Hegenbart U; Wetzels JFM
    Transplantation; 2023 May; 107(5):1056-1068. PubMed ID: 36584374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How I treat monoclonal gammopathy of renal significance (MGRS).
    Fermand JP; Bridoux F; Kyle RA; Kastritis E; Weiss BM; Cook MA; Drayson MT; Dispenzieri A; Leung N;
    Blood; 2013 Nov; 122(22):3583-90. PubMed ID: 24108460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.
    Chauvet S; Frémeaux-Bacchi V; Petitprez F; Karras A; Daniel L; Burtey S; Choukroun G; Delmas Y; Guerrot D; François A; Le Quintrec M; Javaugue V; Ribes D; Vrigneaud L; Arnulf B; Goujon JM; Ronco P; Touchard G; Bridoux F
    Blood; 2017 Mar; 129(11):1437-1447. PubMed ID: 28069603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update to the pathogenesis for monoclonal gammopathy of renal significance.
    Zuo C; Zhu Y; Xu G
    Crit Rev Oncol Hematol; 2020 May; 149():102926. PubMed ID: 32199132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal gammopathy-associated proliferative glomerulonephritis.
    Sethi S; Rajkumar SV
    Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis.
    Li LL; Li ZY; Wang SX; Yu XJ; Tan Y; Wang Y; Yu F; Zhao MH
    BMC Nephrol; 2019 Dec; 20(1):459. PubMed ID: 31823738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.